Staufen Activators
Staufen Activators are a set of chemical compounds that are known to enhance the functional activity of Staufen through various pathways, often by influencing phosphorylation states. Forskolin, by increasing intracellular cAMP levels, could potentially enhance Staufen activity by promoting PKA-dependent phosphorylation, which is crucial for mRNA binding and localization within the cell. Similarly, PMA, as an activator of PKC, could also phosphorylate substrates related to Staufen's function, thus indirectly activating Staufen. The elevation of intracellular calcium by Ionomycin may activate kinases such as CaMK, which again could have implications for Staufen's role in RNA regulation. Sphingosine-1-phosphate signaling through GPCRs might alter cellular pathways that engage Staufen in post-transcriptional gene regulation, while the kinase inhibitor, Epigallocatechin gallate, and the PI3K inhibitor, LY294002, could shift cellular signaling to enhance Staufen-mediated mRNA localization.
In addition to these, cellular analogs and inhibitors that modulate the phosphorylation state of proteins, such as 8-Br-cAMP, Calyculin A, and Okadaic acid, could indirectly influence Staufen activity by affecting the proteins that interact with or regulate Staufen. Anisomycin's activation of MAPK pathways may enhance Staufen's functional activity by increasing the phosphorylation of proteins that govern mRNA metabolism,where Staufen could be implicated. The paradoxical use of PKC inhibitor Go6976 and CaMKII inhibitor KN-93 might also serve to enhance Staufen's activity by altering the phosphorylation state of key regulatory proteins involved in the complex pathways of RNA transport and localization, suggesting a refined regulation of Staufen's activity through a balance of kinase and phosphatase actions. Collectively, these Staufen Activators, by influencing various signaling cascades, serve to enhance the specific biochemical functions of Staufen, which are pivotal in the post-transcriptional regulation of gene expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can enhance Staufen activity by PKA-dependent phosphorylation processes that could affect mRNA binding and localization. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which could phosphorylate substrates that modulate Staufen's RNA binding or localization functions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular Ca2+ concentration, potentially activating Ca2+/calmodulin-dependent protein kinases (CaMK) which could affect Staufen activity related to mRNA regulation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate may activate G-protein coupled receptors (GPCRs) that signal through pathways influencing post-transcriptional gene regulation where Staufen may be involved. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate acts as a kinase inhibitor which could shift signaling pathways to favor those that activate Staufen-mediated mRNA localization. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, altering the AKT signaling pathway, which could indirectly enhance Staufen activity by modifying downstream RNA processing or transport pathways. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA, potentially influencing Staufen activity in RNA transport and localization through PKA-dependent phosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, which could lead to a net increase in phosphorylated states of proteins, potentially influencing Staufen's activity in mRNA binding or localization. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases, which could increase the phosphorylated state of proteins involved in signaling pathways affecting Staufen's role in mRNA regulation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates MAPK pathways, possibly leading to enhanced phosphorylation of proteins that regulate Staufen's function in mRNA metabolism. | ||||||